Systematic review / meta-analysis / 2000
In type 2 diabetes, fish oil supplementation lowered triglycerides and raised LDL cholesterol, but had no significant effect on glycemic control.
A systematic review and meta-analysis evaluated 18 randomized placebo-controlled trials comprising 823 participants with type 2 diabetes receiving fish oil doses of 3 to 18 g/day for a mean of 12 weeks. Pooled data showed fish oil significantly lowered triglycerides (-0.56 mmol/l [95% CI -0.71 to -0.41]) and raised LDL cholesterol (0.21 mmol/l [0.02 to 0.41]). No statistically significant effect was observed for fasting glucose, HbA1c, total cholesterol, or HDL cholesterol. Effects on triglycerides and LDL cholesterol were most pronounced in trials using higher doses and enrolling hypertriglyceridemic subjects, which also explained observed heterogeneity.
- Study type
- Systematic review and meta-analysis of randomized placebo-controlled trials
- Who was studied
- 823 subjects with type 2 diabetes across 18 trials
- What was measured
- Lipid levels and glycemic control
THE PAPER
Fish oil supplementation in type 2 diabetes: a quantitative systematic review.
Montori VM, Farmer A, Wollan PC, Dinneen SF. Diabetes Care, 2000.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.